DNA Nanobots
Powell
About DNA Nanobots
DNA Nanobots is a pioneer in the development and delivery of DNA nanoparticles tailored for targeted therapies. It creates products for targeted chemotherapeutics and functionalized gene delivery. It also offers product development services and expertise in the functionalization of DNA nanotechnology, including experience in gene delivery, vaccine development, targeted drug delivery, and nucleic acid diagnostic testing.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.5M
- Funding stage: Seed
- Last round: Seed (Dec 2025)
- Website: dnananobots.com
- Phone: [email protected]
Industries & Categories
Health Care, Nanotechnology, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/dna-nanobots-76103 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.